<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item><item key="slug">changes-in-gene-expression-resulting-from-expressi</item><item key="name">Changes in gene expression resulting from expression of MN1 in human CD34+ cells</item><item key="sample_count">2</item><item key="tags"><item>acute myeloid leukemia</item><item>bone</item><item>bone marrow</item><item>cell</item><item>leukemia</item><item>myeloid leukemia</item></item><item key="id">3329</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-16745</item><item key="species">human</item><item key="factor_count">0</item></item><item><item key="slug">commonly-altered-genomic-regions-in-acute-myeloid</item><item key="name">Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin-remodeling and splicing</item><item key="sample_count">17</item><item key="tags"><item>acute myeloid leukemia</item><item>histone</item><item>leukemia</item><item>myeloid leukemia</item><item>nucleotide</item><item>point</item></item><item key="id">4517</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-38987</item><item key="species">human</item><item key="factor_count">1</item></item><item><item key="slug">deregulated-apoptosis-signaling-in-core-binding-fa</item><item key="name">Deregulated apoptosis signaling in core binding factor leukemia differentiates clinically relevant, molecular marker independent subgroups</item><item key="sample_count">12</item><item key="tags"><item>acute myeloid leukemia</item><item>cell</item><item>leukemia</item><item>line</item><item>myeloid leukemia</item><item>point</item></item><item key="id">4131</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-29883</item><item key="species">human</item><item key="factor_count">5</item></item><item><item key="slug">determinants-of-sensitivity-to-dznep-induced-apopt</item><item key="name">Determinants of sensitivity to DZNep induced apoptosis in multiple myeloma cells</item><item key="sample_count">8</item><item key="tags"><item>acute myeloid leukemia</item><item>cell</item><item>genome</item><item>leukemia</item><item>line</item><item>multiple myeloma</item><item>myeloid leukemia</item><item>myeloma</item><item>solid</item></item><item key="id">3946</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-26921</item><item key="species">human</item><item key="factor_count">2</item></item><item><item key="slug">effects-of-gene-scilencing-of-usp2-on-expression-p</item><item key="name">Effects of gene scilencing of USP2 on expression profiles of HL60 cells</item><item key="sample_count">24</item><item key="tags"><item>cell</item><item>genome</item><item>leukemia</item><item>myeloid leukemia</item></item><item key="id">2310</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-20476</item><item key="species">human</item><item key="factor_count">3</item></item><item><item key="slug">acute-myeloid-leukemia-with-cebpa-double-mutations</item><item key="name">Acute myeloid leukemia with CEBPA double-mutations harbors in 76.8% of cases concomitant molecular mutations with TET2 and GATA2 alterations demonstrating strong prognostic impact</item><item key="sample_count">38</item><item key="tags"><item>acute myeloid leukemia</item><item>leukemia</item><item>myeloid leukemia</item><item>wt1</item></item><item key="id">2462</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-42064</item><item key="species">human</item><item key="factor_count">2</item></item><item><item key="slug">altered-mirna-and-gene-expression-in-acute-myeloid</item><item key="name">Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance</item><item key="sample_count">12</item><item key="tags"><item>acute myeloid leukemia</item><item>axis</item><item>cell</item><item>inferior</item><item>leukemia</item><item>median</item><item>myeloid leukemia</item></item><item key="id">4542</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-39730</item><item key="species">human</item><item key="factor_count">2</item></item><item><item key="slug">identification-of-protein-kinase-c-beta-2-regulate</item><item key="name">Identification of protein kinase C beta 2 regulated genes early in dendritic cell differentiation</item><item key="sample_count">12</item><item key="tags"><item>acute myeloid leukemia</item><item>cell</item><item>dendritic</item><item>leukemia</item><item>line</item><item>myeloid leukemia</item><item>protein</item></item><item key="id">2131</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-54484</item><item key="species">human</item><item key="factor_count">4</item></item><item><item key="slug">imatinib-therapy-of-chronic-myeloid-leukemia-resto</item><item key="name">Imatinib therapy of chronic myeloid leukemia restores the expression levels of key genes for DNA damage and cell cycle progression</item><item key="sample_count">27</item><item key="tags"><item>bone</item><item>bone marrow</item><item>cell</item><item>chronic myeloid leukemia</item><item>class</item><item>genome</item><item>hematopoietic system</item><item>leukemia</item><item>myeloid leukemia</item></item><item key="id">2166</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-33075</item><item key="species">human</item><item key="factor_count">2</item></item><item><item key="slug">in-vitro-transformation-of-primary-human-cd34-cell</item><item key="name">In Vitro Transformation of Primary Human CD34+ Cells by AML Fusion Oncogenes: Early Gene Expression Profiling Reveals Possible Drug Target in AML</item><item key="sample_count">30</item><item key="tags"><item>acute myeloid leukemia</item><item>leukemia</item><item>myeloid leukemia</item><item>point</item></item><item key="id">2045</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-57194</item><item key="species">human</item><item key="factor_count">2</item></item></data></biogps>
